Evidence map›Paper›PMID 17041563›Full record

ArticleCancer gene therapy2007

International Society for Cell and Gene Therapy of Cancer: 2005 meeting in Shenzhen, China.

B A Guinn, J S Norris, F Farzaneh, A B Deisseroth

Abstract readConference Proceedings
PubMed Publisher
In one paragraph

Article in Cancer gene therapy, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

B A GuinnKing's College London School of Medicine, Department of Haematological Medicine, The Rayne Institute, 123 Coldharbour Lane, London, UK. barbara.guinn@kcl.ac.uk
J S Norris
F Farzaneh
A B Deisseroth

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 2005 International Society for Cell and Gene Therapy of Cancer (ISCGT) Congress was held in Shenzhen, China (www.iscgtchina2005.com) from December 9th-11th 2005. Here, we describe a representation of the most seminal presentations providing an overview of the progress in the field of cancer gene therapy including the successful introduction of the first approved gene therapy drug.

Indexed as

Genetic TherapyAdenoviridaeAnimalsChinaGenes, p53Genetic VectorsHumansLentivirusNeoplasmsRetroviridaeRNA VirusesT-LymphocytesTransgenes

Identifiers

PMID17041563

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.